Psoriasis Completed Phase 2 Trials for Alefacept (DB00092)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00301002Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar PustulosisTreatment
NCT00808223Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe PsoriasisTreatment